Investigation of clinical usefulness of natural indigo ointment for patients with inflammatory bowel disease

Investigation of clinical usefulness of natural indigo ointment for patients with inflammatory bowel disease - Investigation of clinical usefulness of natural indigo ointment for patients with inflammatory bowel disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026072

Enrollment

Registered

2017-03-01

Start date

2017-03-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease

Interventions

Quig-Dai ointment Three times a day Duration of treatment is 1 week

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who is receiving chemotherapy for cancer. 2. Patients with Grade 1 or 2 chemotherapy induced oral mucositis. 3. Age more than 20 years old. Informed consent has been obtained.

Exclusion criteria

Exclusion criteria: 1. Previous adverse effects to Chinese medicine. 2. History of Qing-Dai use within a year. 3. Severe infection. 4. Patients using other drugs for chemotherapy induced oral mucositis. 5. Patients with cancer of oral cavity. 6. Patients with Sjogren's syndrome. 7. Patiens who have previous history of radiotherapy for head and neck. 8. Other conditions not suitable for this study.

Design outcomes

Primary

Measure	Time frame
Feasibility	—

Secondary

Measure	Time frame
Safety and Efficacy	—

Countries

Japan

Contacts

Public ContactKenro Hirata

Keio University School of Medicine Gastroenterology and Hepatology

kenro916@gmail.com0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026